Shares of Johnson & Johnson /zigman2/quotes/201724570/composite JNJ +2.23% rose 1.02% to $165.75 Tuesday, on what proved to be an all-around great trading session for the stock market, with the S&P 500 Index /zigman2/quotes/210599714/realtime SPX +1.17% rising 0.18% to 4,574.79 and the Dow Jones Industrial Average /zigman2/quotes/210598065/realtime DJIA +1.87% rising 0.04% to 35,756.88. This was the stock's third consecutive day of gains. Johnson & Johnson closed $14.17 short of its 52-week high ($179.92), which the company reached on August 20th.
The stock outperformed some of its competitors Tuesday, as Roche Holding AG Part. Cert. /zigman2/quotes/206948568/delayed RHHVF -0.28% rose 0.31% to $391.08, Merck & Co. Inc. /zigman2/quotes/209956077/composite MRK +0.11% rose 0.72% to $82.25, and Pfizer Inc. /zigman2/quotes/202877789/composite PFE -5.14% rose 0.95% to $43.56. Trading volume (6.9 M) eclipsed its 50-day average volume of 6.1 M.